Compare SGHT & CMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGHT | CMT |
|---|---|---|
| Founded | 2011 | 1996 |
| Country | United States | United States |
| Employees | N/A | 1239 |
| Industry | Medical Specialities | Electronic Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.4M | 186.0M |
| IPO Year | 2021 | 1996 |
| Metric | SGHT | CMT |
|---|---|---|
| Price | $4.00 | $22.56 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | $9.08 | ★ $24.00 |
| AVG Volume (30 Days) | ★ 373.6K | 24.4K |
| Earning Date | 03-04-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.16 | N/A |
| EPS | N/A | ★ 1.29 |
| Revenue | $77,363,000.00 | ★ $284,290,000.00 |
| Revenue This Year | $11.81 | $4.49 |
| Revenue Next Year | $10.62 | N/A |
| P/E Ratio | ★ N/A | $17.47 |
| Revenue Growth | N/A | ★ 5.49 |
| 52 Week Low | $2.03 | $13.99 |
| 52 Week High | $9.24 | $22.66 |
| Indicator | SGHT | CMT |
|---|---|---|
| Relative Strength Index (RSI) | 42.49 | 64.82 |
| Support Level | $3.99 | $17.06 |
| Resistance Level | $4.33 | N/A |
| Average True Range (ATR) | 0.22 | 1.11 |
| MACD | 0.09 | 0.27 |
| Stochastic Oscillator | 69.19 | 95.15 |
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
Core Molding Technologies Inc operates in the engineered materials market as one operating segment as a molder of thermoplastic and thermoset structural products. It produces and sells molded products for varied markets, including medium and heavy-duty trucks, automobiles, power sports, construction and agriculture, building products, and other industrial markets. The processes include compression molding of sheet molding compound (SMC), resin transfer molding (RTM), liquid molding of dicyclopentadiene (DCPD), spray-up and hand-lay-up, direct long-fiber thermoplastics (D-LFT) and structural foam and structural web injection molding (SIM). It operates operates in Columbus, Ohio; Gaffney, South Carolina; Winona, Minnesota; Matamoros and Escobedo, Mexico; and Cobourg, Ontario, Canada.